| Cvs Pharmacy #16284 | |
| 1951 W Jefferson Ave, Naperville, Illinois 60540 | |
| (630) 357-0280 |
| Name | Cvs Pharmacy #16284 |
|---|---|
| Organization Name | Highland Park Cvs Llc |
| Location | 1951 W Jefferson Ave, Naperville, Illinois 60540 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (630) 357-0280 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Population Health Impact Institute (PHII) is pleased to announce that Joe Chimera, Ph.D., is the 25th person to receive the Methods Evaluation Process (MEP) Certification.
A research has proven, for the first time, that maternal supplementation with docosahexaenoic acid (DHA), an omega-3 essential polyunsaturated fatty acid, enhances fetal iron metabolism thanks to a greater expression of key genes regulating its transfer through the placenta.
Providing healthcare to the backside workers at Churchill Downs has been the passion of Whitney Nash, PhD, MSN, APRN-BC, assistant professor, University of Louisville School of Nursing, since 2005.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 7 days ago
| NPI Number | 1558383349 |
| Organization Name | HIGHLAND PARK CVS LLC |
| Doing Business As | CVS PHARMACY #16284 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1951 W Jefferson Ave, Naperville, IL 60540 |
| Phone Number | 630-357-0280 |
News Archive
The Population Health Impact Institute (PHII) is pleased to announce that Joe Chimera, Ph.D., is the 25th person to receive the Methods Evaluation Process (MEP) Certification.
A research has proven, for the first time, that maternal supplementation with docosahexaenoic acid (DHA), an omega-3 essential polyunsaturated fatty acid, enhances fetal iron metabolism thanks to a greater expression of key genes regulating its transfer through the placenta.
Providing healthcare to the backside workers at Churchill Downs has been the passion of Whitney Nash, PhD, MSN, APRN-BC, assistant professor, University of Louisville School of Nursing, since 2005.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 7 days ago
News Archive
The Population Health Impact Institute (PHII) is pleased to announce that Joe Chimera, Ph.D., is the 25th person to receive the Methods Evaluation Process (MEP) Certification.
A research has proven, for the first time, that maternal supplementation with docosahexaenoic acid (DHA), an omega-3 essential polyunsaturated fatty acid, enhances fetal iron metabolism thanks to a greater expression of key genes regulating its transfer through the placenta.
Providing healthcare to the backside workers at Churchill Downs has been the passion of Whitney Nash, PhD, MSN, APRN-BC, assistant professor, University of Louisville School of Nursing, since 2005.
Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.
› Verified 7 days ago
Active Medical Center Type: Medicare Supplier Location: 1811 Freedom Dr, Naperville, Illinois 60563 Phone: (630) 225-8750 | |
Advanced Health Type: DME Supplier - Customized Equipment Location: 1924 Springbrook Square Dr, Naperville, Illinois 60564 Phone: (630) 527-9950 | |
Osco Drug #0058 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 95th St, Naperville, Illinois 60564 Phone: (630) 904-7709 | |
Osco Drug #0059 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1755 W Ogden Ave, Naperville, Illinois 60540 Phone: (630) 637-1370 | |
Osco Drug #0185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 127 E Ogden Ave, Naperville, Illinois 60563 Phone: (630) 357-1040 |